Male Reproductive Cancers Resource Center
While data confirmation is needed, recent findings may prove beneficial in identifying patients at a high risk of developing prostate cancer.
FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.
Male Reproductive Cancers News
Earlier androgen deprivation therapy may increase death risk, but earlier docetaxel may lower it.
More Male Reproductive Cancers Resources
This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.
This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.
This fact sheet provides information on symptoms, pain, causes, and treatments for testicular, testicle cancer.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Ipilimumab Can Be Infused Safely Over 30 Minutes
- Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies
- Link Between Citrus Consumption and Melanoma
- Bevacizumab with Chemo Improves Survival in Ovarian Cancer with Poor Prognosis
- Anabolic Response of Essential Amino Acid Mixtures in Advanced Lung Cancer
- High-Dose CRT Plus Watchful Waiting May Be Safe Alternative for Distal Rectal Cancer
- Final OS Results from the Phase 3 OPTIMAL Trial in EGFR-Positive NSCLC
- Statin Use Tied to Better Post-Surgical Outcomes
- Statin Therapy May Help Delay Prostate Cancer Progression in Men Receiving ADT
- Ibrutinib Plus Ofatumumab Tolerable, Active for Relapsed CLL
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|